MedTrace Logo

Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections

NCT01105013 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2012-04-12

No results posted yet for this study

Summary

This is a study clinical, multicenter, Phase III trial, to evaluate the efficacy and safety of tolnaftate cream in the treatment of patients with fungal infections such as Tinea foot, Tinea and Tinea crural body.

Conditions

  • Fungal Infections
  • Tinea Pedis
  • Tinea Cruris
  • Tinea Corporis

Interventions

DRUG

Clotrimazole

Apply the product in sufficient quantity to cover the affected area 2 times daily (every 12 hours) for 60 days.

Sponsors & Collaborators

  • Laboratório Teuto Brasileiro S/A

    lead INDUSTRY

Principal Investigators

  • Dagoberto Brandão · PHC - Pharma Consulting

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01105013 on ClinicalTrials.gov